SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-309149
Filing Date
2014-08-14
Accepted
2014-08-14 07:01:10
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d754084d10q.htm 10-Q 266314
2 EX-31.1 d754084dex311.htm EX-31.1 5775
3 EX-32.1 d754084dex321.htm EX-32.1 2996
  Complete submission text file 0001193125-14-309149.txt   2649478

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rxii-20140630.xml EX-101.INS 310169
5 XBRL TAXONOMY EXTENSION SCHEMA rxii-20140630.xsd EX-101.SCH 22950
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20140630_cal.xml EX-101.CAL 34828
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20140630_def.xml EX-101.DEF 109969
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20140630_lab.xml EX-101.LAB 225664
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20140630_pre.xml EX-101.PRE 182337
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 141039402
SIC: 2834 Pharmaceutical Preparations